Women's Health

A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.

A study of women aged 50 to 69 years found that thrombotic risk varied by route of administration, estradiol dose, and duration of use.

With obesity, muscle loss, and sleep disorders so prominent in postmenopause, providers are now looking into further expansion of GLP-1 use.

Menopause status and symptoms are inconsistently captured in electronic health records, leaving a gap in care for patients.

Data found reduced cardiovascular risk with hormone therapy, particularly among Black women and those starting treatment within 10 years of menopause.

Researchers assess the neurological outcomes of over 200,000 children exposed to COVID-19 before birth.

Madeline Sutton, MD, MPH, FACOG, joins to discuss risks of HPV infection among women and how pharmacists can improve outcomes in this area.

Data show postmenopausal women using hormone replacement therapy may have a 10% lower risk of developing dementia.

Once maternal major depressive disorder is disentangled from drug exposure, SSRIs carry little or no added risk in pregnancy, according to analysis.

With reproductive and obstetric care services waning in the US, researchers explore how patients see pharmacists filling gaps in care.

New analysis finds Black, Hispanic, unmarried, and Medicaid-enrolled women bore the heaviest burden of pandemic-related stressors during pregnancy.

Natalie DiPietro Mager, PharmD, PhD, meets with Sally Rafie, PharmD, BCPS, to explore misinformation on contraception and other women’s health topics.

Data show possible but insignificant reduction in hypertensive disorders of pregnancy after periconceptional or first-trimester GLP-1 exposure.

Every pattern of hormonal contraceptive use was associated with subsequent semaglutide initiation, a signal pharmacists and prescribers should watch for.

New survey data reveal information gaps in respiratory syncytial virus immunization decisions.

Viatris' new transdermal patch adds a low-dose estrogen option to the contraceptive landscape.

Researchers explore prenatal alcohol use among expectant mothers in the US spanning 2011 to 2024.

A new survey shows widespread uncertainty about which vaccines the CDC recommends during pregnancy, underscoring the counseling role pharmacists play.

Pharmacists and other clinicians counseling postpartum patients may find more success with meal-timing strategies that require minimal disruption to routines.

In this episode, Natalie DiPietro Mager, PharmD, PhD, talks with Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, about how pharmacists can address cannabis use in women during adolescence, reproductive years, and older adulthood.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Alyssa Perry, PharmD to discuss the pharmacist’s role in ensuring inclusive and respectful care for members of the LGBTQ+ community.

This schedule arrives at a time of unprecedented friction between leading medical societies and federal health agencies.

Pharmacists help women choose safer hormone replacement therapy or nonhormonal relief options.

Learn practical do’s and don’ts for male pharmacists to deliver private, inclusive, evidence-based birth control counseling patients trust.

In a health care landscape of silos and fragmentation, especially in the menopause space, pharmacists have increasingly provided their efforts to better care coordination for their communities.